Goldman Sachs’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.16M Buy
1,043,310
+14,632
+1% +$30.3K ﹤0.01% 3367
2025
Q1
$2.26M Buy
1,028,678
+373,518
+57% +$822K ﹤0.01% 3282
2024
Q4
$1M Sell
655,160
-1,051,992
-62% -$1.61M ﹤0.01% 3915
2024
Q3
$3.4M Buy
1,707,152
+292,083
+21% +$581K ﹤0.01% 3013
2024
Q2
$4.95M Buy
1,415,069
+14,665
+1% +$51.3K ﹤0.01% 2614
2024
Q1
$3.88M Buy
1,400,404
+415,753
+42% +$1.15M ﹤0.01% 2773
2023
Q4
$1.67M Buy
984,651
+378,845
+63% +$644K ﹤0.01% 3318
2023
Q3
$624K Buy
605,806
+39,742
+7% +$40.9K ﹤0.01% 3786
2023
Q2
$657K Buy
566,064
+161,755
+40% +$188K ﹤0.01% 3835
2023
Q1
$611K Sell
404,309
-748,642
-65% -$1.13M ﹤0.01% 3978
2022
Q4
$2.88M Sell
1,152,951
-1,146,102
-50% -$2.87M ﹤0.01% 3025
2022
Q3
$9.7M Buy
2,299,053
+1,024,354
+80% +$4.32M ﹤0.01% 2147
2022
Q2
$3.56M Sell
1,274,699
-1,004,899
-44% -$2.8M ﹤0.01% 2968
2022
Q1
$13M Buy
2,279,598
+361,188
+19% +$2.07M ﹤0.01% 2022
2021
Q4
$17.5M Buy
1,918,410
+316,554
+20% +$2.89M ﹤0.01% 1852
2021
Q3
$17.1M Buy
1,601,856
+908,890
+131% +$9.72M ﹤0.01% 1867
2021
Q2
$10.8M Sell
692,966
-532,319
-43% -$8.26M ﹤0.01% 2198
2021
Q1
$19.9M Buy
1,225,285
+77,343
+7% +$1.25M 0.01% 1687
2020
Q4
$24.3M Buy
1,147,942
+114,958
+11% +$2.43M 0.01% 1430
2020
Q3
$15.3M Sell
1,032,984
-153,971
-13% -$2.28M ﹤0.01% 1664
2020
Q2
$17.5M Sell
1,186,955
-298,572
-20% -$4.39M 0.01% 1562
2020
Q1
$17.4M Sell
1,485,527
-52,092
-3% -$612K 0.01% 1417
2019
Q4
$36.1M Buy
1,537,619
+847,578
+123% +$19.9M 0.01% 1225
2019
Q3
$12.8M Sell
690,041
-62,370
-8% -$1.15M ﹤0.01% 1806
2019
Q2
$14M Sell
752,411
-38,660
-5% -$719K ﹤0.01% 1787
2019
Q1
$19.3M Buy
791,071
+94,665
+14% +$2.31M 0.01% 1633
2018
Q4
$18.1M Buy
696,406
+153,086
+28% +$3.97M 0.01% 1579
2018
Q3
$17.2M Buy
543,320
+63,293
+13% +$2M ﹤0.01% 1730
2018
Q2
$18.6M Buy
480,027
+167,595
+54% +$6.51M 0.01% 1657
2018
Q1
$8.62M Buy
312,432
+166,560
+114% +$4.6M ﹤0.01% 2016
2017
Q4
$2.64M Sell
145,872
-130,031
-47% -$2.35M ﹤0.01% 2679
2017
Q3
$4.46M Sell
275,903
-142,377
-34% -$2.3M ﹤0.01% 2433
2017
Q2
$5.79M Buy
418,280
+198,562
+90% +$2.75M ﹤0.01% 2201
2017
Q1
$3.3M Buy
219,718
+192,604
+710% +$2.89M ﹤0.01% 2448
2016
Q4
$355K Sell
27,114
-10,703
-28% -$140K ﹤0.01% 3629
2016
Q3
$652K Buy
37,817
+29,404
+350% +$507K ﹤0.01% 3283
2016
Q2
$152K Sell
8,413
-146,258
-95% -$2.64M ﹤0.01% 3974
2016
Q1
$2.94M Buy
154,671
+107,754
+230% +$2.05M ﹤0.01% 2330
2015
Q4
$1.25M Sell
46,917
-689,922
-94% -$18.4M ﹤0.01% 2779
2015
Q3
$18M Buy
736,839
+721,568
+4,725% +$17.6M 0.01% 1329
2015
Q2
$476K Buy
+15,271
New +$476K ﹤0.01% 3388
2014
Q3
Sell
-39,986
Closed -$493K 4539
2014
Q2
$493K Buy
39,986
+23,183
+138% +$286K ﹤0.01% 3362
2014
Q1
$234K Buy
+16,803
New +$234K ﹤0.01% 3834